According to Zai Lab's latest financial reports and stock price the company's current Operating Margin is -156.07%. At the end of 2022 the company had an Operating Margin of -206.04%.
Year | Operating Margin | Change |
---|---|---|
2022 | -206.04% | -57.73% |
2021 | -487.43% | -10.83% |
2020 | -546.60% | -65.07% |
2019 | -1,564.88% | -98.54% |
2018 | -106,949.81% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | -76.70% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 5,276.53% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.